Brain microbleeds and Alzheimer's disease: innocent observation or key player?

被引:236
作者
Cordonnier, Charlotte [1 ]
van der Flier, Wiesje M. [2 ,3 ,4 ]
机构
[1] Univ Lille Nord France, CHU Lille, EA 1046, F-59000 Lille, France
[2] Vrije Univ Amsterdam, Med Ctr, Alzheimer Ctr, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands
关键词
brain microbleeds; Alzheimer's disease; dementia; CEREBRAL AMYLOID ANGIOPATHY; APOLIPOPROTEIN-E EPSILON-4; SMALL-VESSEL DISEASE; COGNITIVE FUNCTION; INTRACEREBRAL HEMORRHAGE; SUPERFICIAL SIDEROSIS; SENILE PLAQUES; RISK-FACTORS; BIOMARKERS; PREVALENCE;
D O I
10.1093/brain/awq321
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Brain microbleeds are small dot-like lesions appearing as hyposignals on gradient echo magnetic resonance sequences. In Alzheimer's disease, brain microbleeds are of special interest as they may play a crucial role in the pathophysiology. They may be a missing link between two important theories on the neuropathogenesis of Alzheimer's disease-the amyloid cascade hypothesis and the vascular hypothesis. Moreover, they may affect the clinical course of the disease and may have therapeutic consequences. The aim of this article is to review available data to understand the meaning of brain microbleeds in clinical terms and underlying pathology in the context of Alzheimer's disease. We also review the available evidence and highlight the pitfalls of our current knowledge on brain microbleeds in the setting of clinical trials design.
引用
收藏
页码:335 / 344
页数:10
相关论文
共 64 条
[1]   Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial [J].
不详 .
LANCET NEUROLOGY, 2008, 7 (01) :41-49
[2]   Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms [J].
Attems, J .
ACTA NEUROPATHOLOGICA, 2005, 110 (04) :345-359
[3]   Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD [J].
Bayer, AJ ;
Bullock, R ;
Jones, RW ;
Wilkinson, D ;
Paterson, KR ;
Jenkins, L ;
Millais, SB ;
Donoghue, S .
NEUROLOGY, 2005, 64 (01) :94-101
[4]   CSF markers for incipient Alzheimer's disease [J].
Blennow, K ;
Hampel, H .
LANCET NEUROLOGY, 2003, 2 (10) :605-613
[5]   Vascular risk factors for Alzheimer's disease: An epidemiologic perspective [J].
Breteler, MMB .
NEUROBIOLOGY OF AGING, 2000, 21 (02) :153-160
[6]   Nerve inflammation halts trial for Alzheimer's drug [J].
Check, E .
NATURE, 2002, 415 (6871) :462-462
[7]   Prevalence and severity of microbleeds in a memory clinic setting [J].
Cordonnier, C ;
van der Flier, WM ;
Sluimer, JD ;
Leys, D ;
Barkhof, F ;
Scheltens, P .
NEUROLOGY, 2006, 66 (09) :1356-1360
[8]   Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting [J].
Cordonnier, Charlotte ;
Salman, Rustarn Ai-Shahi ;
Wardlaw, Joanna .
BRAIN, 2007, 130 :1988-2003
[9]   What are the causes of pre-existing dementia in patients with intracerebral haemorrhages? [J].
Cordonnier, Charlotte ;
Leys, Didier ;
Dumont, Frederic ;
Deramecourt, Vincent ;
Bordet, Regis ;
Pasquier, Florence ;
Henon, Hilde .
BRAIN, 2010, 133 :3281-3289
[10]  
Cordonnier Charlotte, 2010, Pract Neurol, V10, P94, DOI 10.1136/jnnp.2010.206086